Sana Biotechnology EVP and President of R&D Resigns
Company Announcements

Sana Biotechnology EVP and President of R&D Resigns

Sana Biotechnology (SANA) just unveiled an announcement.

Douglas Williams, Ph.D., has voluntarily resigned from his roles as Executive Vice President and President of Research and Development at Sana Biotechnology, Inc., effective April 18, 2024. His departure is for personal reasons and does not stem from any disputes with the company.

See more insights into SANA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySana Biotechnology CFO Nathan Hardy resigns, effective October 4
GlobeNewswireSana Biotechnology to Present at September 2024 Investor Conferences
TheFlySana Biotechnology appoints Dhaval Patel, M.D., CSO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App